XBiotech Inc.: XBiotech to Launch Novel Candidate Therapy for Stroke
Company Commencing Phase I/II Study to Test Safety and Efficacy of its New Drug Candidate to Reduce Brain Injury After StrokeAUSTIN, Texas, Oct. 28, 2021 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced
Source: finanznachrichten.de